We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $911M
1-Year Est. Return 51.11%
This Fund
S&P 500
This Quarter Est. Return
+9.53%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$863M
AUM Growth
-$116M
Cap. Flow
-$181M
Cap. Flow %
-20.99%
Top 10 Hldgs %
44.59%
Holding
88
New
26
Increased
10
Reduced
22
Closed
20

Sector Composition

Rank Sector Weight
1 Healthcare 19.79%
2 Technology 12.94%
3 Consumer Discretionary 11.65%
4 Communication Services 10.07%
5 Industrials 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ON icon
26
ON Semiconductor
ON
$29.9B
$12.2M 1.41%
318,200
-45,000
-12% -$1.77M
FIS icon
27
Fidelity National Information Services
FIS
$22.1B
$11.6M 1.34%
81,900
DHR icon
28
Danaher
DHR
$140B
$11.6M 1.34%
48,625
-27,966
-37% -$6.2M
FOUR icon
29
Shift4
FOUR
$4.23B
$11.2M 1.3%
119,870
-38,951
-25% -$3.68M
PAGS icon
30
PUT
PagSeguro Digital
PAGS
$2.63B
$10.3M 1.2%
+185,000
New +$8.9M
SLGL icon
31
Sol-Gel Technologies
SLGL
$288M
$10.3M 1.19%
83,280
CRIS icon
32
Curis
CRIS
$8.85M
$9.92M 1.15%
+3,073
New +$13.9M
WSC icon
33
WillScot Mobile Mini Holdings
WSC
$4.81B
$9.77M 1.13%
+350,670
New +$10.1M
BKR icon
34
Baker Hughes
BKR
$61.2B
$9.33M 1.08%
+408,000
New +$9.42M
TWLO icon
35
Twilio
TWLO
$29.3B
$8.36M 0.97%
21,205
-8,245
-28% -$2.86M
TDG icon
36
TransDigm Group
TDG
$70.2B
$8.32M 0.96%
+12,850
New +$8.06M
GTYH
37
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
$8.24M 0.96%
1,159,600
XLRN
38
DELISTED
Acceleron Pharma
XLRN
$8.16M 0.95%
+65,000
New +$8.2M
MTEM
39
DELISTED
Molecular Templates, Inc.
MTEM
$7.91M 0.92%
67,433
+3,333
+5% +$436K
SE icon
40
Sea Limited
SE
$70.4B
$7.81M 0.9%
28,436
+2,036
+8% +$517K
FLXN
41
DELISTED
Flexion Therapeutics, Inc.
FLXN
$7.35M 0.85%
893,580
-175,000
-16% -$1.49M
GS icon
42
Goldman Sachs
GS
$313B
$7.33M 0.85%
+19,300
New +$6.91M
RAPT
43
CALL
DELISTED
RAPT Therapeutics
RAPT
$6.36M 0.74%
25,000
+6,250
+33% +$1.17M
TVRD
44
Tvardi Therapeutics
TVRD
$18.8M
$6.17M 0.71%
12,005
-8,178
-41% -$5.18M
QURE icon
45
CALL
uniQure
QURE
$3.07B
$6.16M 0.71%
+200,000
New +$6.7M
WDAY icon
46
Workday
WDAY
$42.1B
$5.01M 0.58%
21,000
-20,292
-49% -$4.88M
SCYX icon
47
SCYNEXIS
SCYX
$51.2M
$4.69M 0.54%
79,631
+6,250
+9% +$394K
GNCA
48
DELISTED
Genocea Biosciences, Inc.
GNCA
$4.62M 0.53%
1,972,056
PRAX icon
49
Praxis Precision Medicines
PRAX
$8.9B
$4.57M 0.53%
+16,667
New +$5.97M
XAIR icon
50
Beyond Air
XAIR
$4.1M
$4.5M 0.52%
1,738

Similar funds

Kingdon Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Kingdon Capital Management held 88 positions worth $863M, down 12% from $979M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Kingdon Capital Management withdrew a net $181M in Q2 2021, closing 20 positions and reducing 22 holdings. Its most notable exit was Citigroup, an estimated $14.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Kingdon Capital Management opened a new position in Advanced Micro Devices worth $23.5M.

  • Kingdon Capital Management's largest Q2 2021 buy was Advanced Micro Devices: 250,000 shares worth $23.5M.
  • Kingdon Capital Management added most to Amazon in Q2 2021, an estimated $31.5M increase.
  • Kingdon Capital Management's biggest Q2 2021 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $37.3M.
  • Kingdon Capital Management fully exited Citigroup in Q2 2021, selling an estimated $14.6M.
  • Kingdon Capital Management's ten largest holdings make up 45% of its $863M portfolio in Q2 2021.
  • Kingdon Capital Management opened 26 new positions and closed 20 in Q2 2021.
  • Kingdon Capital Management's portfolio value fell 12% quarter-over-quarter to $863M.

Based on Kingdon Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.